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Antibodies are known to play an important role in the control of malaria infection. However, they can modulate 
parasite development enhancing infection. The effect of anti-Plasmodium antibodies on the expression of 
circumsporozoite protein gene (csp) was investigated. Plasmodium falciparum 3D7 in vitro cultures were submitted to: i) 
anti- circumsporozoite protein monoclonal antibody (anti-CSP-mAb) [1μg/ml, 0.1μg/ml, 0.01μg/ml and 0.001μg/ml] 
and ii) purified IgG Fab fragment from a pool of malaria patients [1mg/ml and 1μg/ml]; and compared to control 
cultures. After 24h the number of ring infected erythrocytes was determined in order to calculate invasion efficacy. At 
48h culture supernatant was collected, and the amount of circumsporozoite protein determined by ELISA, parasitaemia 
was calculated and cells were processed for RNA preparation. Expression of csp gene was quantified using Real time 
RT-PCR. There was an increase in parasite growth when treated with lower anti-CSP-mAb concentration, which was 
associated with lower csp expression, while 1μg/ml anti-CSP-mAb treatment presented a growth inhibitory effect 
accompanied by high csp expression.  
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1.  INTRODUCTION 
Recognition of pathogen molecules by antibodies 
leads to initiation of immune response. Binding of 
antibodies to pathogen molecules can disable pathogens or 
mediate destruction by other effector mechanisms. The role 
of antibodies during infection can vary from protection to 
pathogenesis. Further, antibodies can exert direct effect on 
the pathogen, modulating development and evasion to the 
immune system. Antibody modulation of expression and 
pathogen transcription levels has been described in virus. 
Antibodies to measles virus molecules expressed at the 
surface of infected cells can alter expression of 
polypeptides present in the cytoplasm of infected cells as 
well as those present at the plasma membrane [1]. 
Antibody modulation is not exclusive of virus, in vitro 
treatment of rabbit endothelial cells with specific anti-
endothelial antibodies resulted in redistribution of antigens 
in the cell as well as co-redistribution of immunological 
unrelated antigens [2]. The inhibitory effect of antibodies 
on malaria development has been well documented. 
However, antibodies are also capable of modulating 
positively parasite development. Depending upon time of 
infection, anti-P. falciparum sporozoite antibodies can 
influence sporogonic development. When infected 
mosquitoes were membrane-fed, at day 5 post-infection 
(p.i.), with antibodies anti-P. falciparum sporozoite or anti- 
circumsporozoite protein (CSP) the absolute number of 
sporozoites recovered from the mosquito salivary glands at 
day 14 p.i. was significantly higher [3, 4]. Anti-gamete 
antibodies, which can suppress infectivity of P. vivax to the 
mosquito vector, at lower concentrations had the opposite 
effect, enhancing parasite numbers [5]. Nudelman and 
colleagues [6] also reported a similar effect of lower anti-
Plasmodium antibody concentration. The number of mature 
liver schizonts increased up to 150% in the presence of 
mAbs anti-CSP of P. yoelii, which were suppressive at 
higher concentrations. Contradictory effects of antibodies 
on parasite development have also been described in the 
asexual stages of human malaria parasite P. falciparum. The 
presence of Kenyan immune serum in FC27 P. falciparum 
cultures had an inhibitory effect after 48h in culture. In 
contrast purified IgG, isolated from the same serum 
samples enhanced parasite growth up to 66% [7]. The 
circumsporozoite protein (CSP) is a major parasite surface 
protein during the sporogonic cycle. It is highly 
immunogenic, and in endemic areas high antibody titters 
against this protein are observed in circulating blood. This 
study sets to understand the role of anti-Plasmodium 
antibodies on the erythrocytic development of Plasmodium 
falciparum and their effect on the expression of csp gene. 
2.  Materials and Methods 
Parasites and cultures 
P. falciparum 3D7 was maintained in culture as 
described by Trager and Jensen [8]. Cultures were 
synchronised by two rounds of sedimentation using 
gelatine. Briefly, cultures of approximately 5% parasitised 
erythrocytes (PE) were centrifuged, the pellet obtained was 
resuspended in 9 volumes of pre-warmed gelatin solution 
(0.75% in Heppes-buffered RPMI 1640), and cultures were 
incubated for 45 min at 37 º C. The upper layer was 
collected and centrifuged; pellet was adjusted for a 5% 
haematocrite and cultured at 37ºC for 48h. A second round 
of synchronisation was performed prior to the assay. 
Erythrocytes were sedimented by centrifugation at 
2000g. Fresh washed non-infected erythrocytes were added 
to the pellet in order to obtain 2% PE. Culture haematocrite 
was adjusted to 5%. The obtained culture was divided in 
3ml aliquots and centrifuged for 10min at 2000g. 
Supernatant was removed and replaced by fresh RPMI 
media supplemented with 10% heat inactivated serum and 
one of the following treatments: a) no other supplement - Int. J. Med. Sci. 2006, 3 
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control; b) 1mg/ml and 1μg/ml purified IgG Fab fragment 
isolated from a pool of 750 malaria patients from Malawi, 
kindly provided by Prof. Hommel through Dr. Armada, 
Liverpool Scholl of Tropical Medicine, UK; c) 1 – 0.1 – 0.01 
and 0.001 μg/ml anti-CSP monoclonal antibody (2A10-
HA2) kindly provided by Dr. Wirtz, CDC, Atlanta, Georgia 
USA. Parasites were cultured for 24 or 48h in a CO2 rich 
environment. Blood smears were performed at 24 and 48 h. 
After 48h culture media and cells were collected for ELISA 
and RNA extraction respectively. 
RNA preparation and cDNA synthesis 
Extraction of total RNA was performed with Trizol 
(Life Technologies) according to the manufacturer’s 
protocol. One microgram of total RNA from each sample 
was treated  with 1U of DNase I (Life Technologies). 
Complementary DNA (cDNA) was synthesised in a 20 µl 
reaction with 1 µg treated RNA, 0.5μg oligo(dT)15, 50mM 
Tris-HCl pH 8.3, 75mM KCl, 1,5mM MgCl2, 10mM BSA, 
0.5mM dNTP’s, and 10U MMLV-RT (Life Technologies). 
RNA was retrotranscribed for 1 hour at 37ºC, denatured 5 
min at 95ºC and quenched on ice. To certify the absence of 
genomic DNA (gDNA), duplicates of samples were 
incubated with a similar cDNA reaction mixture devoid of 
RT enzyme. No RNA controls were included for each 
reaction mixture used. 
Real-Time Reverse Transcriptase-PCR Analysis 
Gene-specific primers for P. falciparum ldh [9] and csp 
[10] genes were synthesised by Life Technologies and used 
in a reaction mixture using SYBR
® Green PCR Core 
reagents kit (PE Applied Biosystems). PCR reactions were 
performed in a volume of 20µl containing the following 
primer concentrations: ldh (0.3mM -fwd, 0.05mM-rev), csp 
(0.1mM -fwd, 0.3mM-rev). Each reaction contained 1µl of 
cDNA template. Amplification  and detection of specific 
products was performed with the GeneAmp
® 5700 system 
(PE Applied Biosystems) using the following cycle profile: 
1 cycle at 48°C for 30 min, 1 cycle at 95°C for 10 min, 40 
cycles at 95°C for 15 s, and 60°C for 1 min.  
Quantification relies on the comparison of the critical 
threshold cycle (Ct) of an unknown sample against a 
standard curve of known quantities. Ct is the amplification 
cycle at which the fluorescence becomes detectable and is 
inversely proportional to the logarithm of the initial 
amount of template DNA. For each reaction a standard 
curve was plotted with Ct values obtained from 
amplification of known quantities of gDNA (100, 10, 1, 0.1 
and 0.01ng) isolated from P. falciparum 3D7 clone. 
Concentration of DNA was determined by 
spectrophotometric analysis of optical density at 260nm 
(GeneQuant, Pharmacia) and standard DNA solutions 
were prepared. A standard curve was used to transform Ct 
values to the relative  number of DNA molecules. 
Triplicates of each sample and standard curve were 
performed in all assays. The quantity of cDNA for csp was 
normalised to the quantity of the house keeping gene ldh 
cDNA in each sample. Melting curves were used to 
determine the specificity of PCR products. 
ELISA for detection of circumsporozoite protein (CSP) 
Microtitration plates were coated with PBS containing 
0.2μg/well capture antibody (Pf-CAP, lot. TF097, CDC, 
Atlanta) and incubated overnight at room temperature. 
Coating solution was replaced with blocking buffer (0.5% 
Casein, 0.1N NaOH, PBS pH7.4, 20mg/l phenol red) and 
incubated at RT for one hour. P. falciparum 3D7 48h culture 
supernatant was centrifuged at 2000g to remove debris. 
Blocking buffer in the wells was replaced with 100μl of 
culture supernatant and incubated for 1h. Fresh culture 
medium was used as negative controls. For each plate a 
titration (100 – 0.75pg) of recombinant positive control (Pf-
PC, lot R32, CDC, Atlanta) was added. The wells were then 
washed twice with PBS Tween20. Peroxidase conjugate 
antibody diluted in blocking buffer (0.05μg) was added to 
each well. After 2h of incubation, plates were washed 3 
times with PBS Tween20, and peroxidase substrate added. 
The absorbance was read at 414 nm. The standard curve 
was used to quantify the amount of CSP present in the 
samples. ELISA mAbs and positive control were acquired 
from Dr. Wirtz, CDC, Atlanta, GA USA. 
Statistical analyses  
Data analysis was performed using SPSS statistical 
program. The Wilcoxon signed-rank test, for 2 matched 
samples was used to evaluate differences between groups. 
The significant level was taken as p<0.05. 
3.  Results 
At starting of experiments parasitaemia was set to 
approximately 2% PE. Blood smears were performed to 
confirm parasitaemia that varied from 1.9 to 2.1 
(percentage of ring stages/ early trophozoite varied 87 to 
97%). After 48h of culture all controls showed an increase 
in parasite number with total parasitaemia varying from 
2.9 to 4.1. There were no statistical significant differences 
between control and treated parasites. However, we 
observed a decrease in the mean number of parasites when 
treated with 1μg mAb/ml. Anti-CSP-mAb had 
contradictory effect depending on concentration and 
although mAb at lower concentration seems to have a 
stimulatory effect, in this group the variability between 
experiments was high. The opposite was observed in 
parasites treated with IgG (Fig. 1).  
Figure 1. P. falciparum 3D7 in vitro growth. Parasites were 
submitted for 48h to different antibody treatments: 1μg/ml and 
0.001μg/ml anti-CSP monoclonal antibody (mAb); 1mg/ml and 
1μg/ml purified IgG Fab fragment isolated from a pool of 750 
malaria patients from Malawi. Cultures were set for 2% 
parasitaemia (87-97 % ring stage parasites) and 5% heamatocrit 
and were cultured for 48 hours. Percentage of parasite 
increase/decrease was calculated by dividing parasitaemia of 
treated cultures over control cultures (control = 100%). 
Parasitaemia of 3 replicates per experiment was counted. Data 
represents mean increase of ring stage parasites ( - ) and 
schizonts (+) of 5 independent experiments. Boxes represent 
standard error of the mean [open – ring stages; solid – schizonts] 
and whiskers represent standard deviation of the mean.  
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In order to investigate if antibodies were exerting an 
effect on invasion, serial dilutions of mAb anti-CSP were 
tested in the culture medium. After synchronisation, the 
percentage of schyzonts varied from 88 to 90% [Initial % 
parasitaemia was 1.98 +/- 0.11 (mean +/- SD)]. Parasites 
were cultured for 24h and ring-stage infected erythrocytes 
were counted [control ring-stage % parasitaemia was 3.07 
+/- 0.73 (mean +/- SD)]. Efficacy of invasion was 
calculated as the percentage of ring infected erythrocytes of 
test cultures over the percentage of ring infected 
erythrocytes in control culture (Fig. 2). When anti-CSP 
mAb was present in the culture we observed a dose 
dependent decrease in invasion, that was inverted when 
parasites were treated with the lowest concentration 
(1ng/ml mAb) presenting an increase of invasion. 
Although, close to significant level this increase was not 
significantly different from the control (p=0.0578).  
Figure 2. Effect of anti-CSP monoclonal antibody (mAb) on P. 
falciparum 3D7 merozoite invasion. Purified schizonts (88-90 %) 
were cultured for 24h with human erythrocytes in order to 
measure the ability of merozoite to invade erythrocytes in the 
presence of  1- 0.1 – 0.01 and 0.001μg/ml anti-CSP monoclonal 
antibody (mAb). The number of ring stage infected erythrocytes 
of 3 replicates was counted. Efficacy of invasion was calculated 
as the percentage of ring infected erythrocytes of treated cultures 
over the percentage of ring infected erythrocytes in control 
culture (control = 100%). Boxes represent standard error of the 
mean and whiskers represent standard deviation of the mean.  
 
 
No amplification was observed when cDNA controls, 
that lack the reverse transcriptase enzyme, were used in 
the real time PCR reactions, demonstrating that there was 
no gDNA contamination. PCR reaction triplicates showed 
no major differences among them and expression levels of 
the internal control were similar in the different 
experiments. The expression levels of csp gene were 
depressed when parasites were submitted to 1ng/ml mAb 
(p=0.042) and 1mg/ml IgG Fab fragment (p=0.0796), while 
with the other treatments expression of csp was maintained 
similar or higher than the control (Fig. 3). Although 
differences between experiments were observed, a similar 
trend was seen between them.  
Figure 3. Expression levels of P. falciparum 3D7 gene that codes 
for the circumsporozoite protein (csp). Parasites were cultured 
with: 1μg/ml and 0.001μg/ml anti-CSP monoclonal antibody 
(mAb); 1mg/ml and 1μg/ml purified IgG Fab fragment isolated 
from a pool of 750 malaria patients from Malawi. Cultures were 
set for 2% parasitaemia (87 to 97% ring stage parasites) and 5% 
haematocrit and were cultured for 48 hours. Quantification of 
cDNA was determined against a standard curve and normalised 
by the amount of ldh expression. Percentage of increase/decrease 
expression was calculated by dividing treated cultures over 
control cultures (control = 100%). Values represent the mean and 
standard error of 4 independent experiments.  
 
 
The presence of CSP was quantified in culture 
supernatants using a sandwich ELISA. Levels of CSP 
production into the media were very low in 48h culture 
supernatant [varying from 0.85 pg/ml +/- 0.02 to 0.93 
pg/ml +/-0.01 (mean +/- SD)] and showed no differences 
between treatments. 
4.  Discussion  
Antibodies are known to play an important role in the 
control of malaria infection. Since the early studies 
demonstrating that antibodies transferred from immune 
individuals diminish P. falciparum parasitaemia [11] a lot of 
effort has been put forward to identify parasite epitopes 
and mechanisms of action of antibody-mediated immune 
response to malaria. Besides their role in infection control, 
antibodies can modulate parasite development in the 
sporogonic [3 - 5], exoerythrocytic [6] and erythrocytic [7] 
cycle. However, there is almost no information on the 
effect of antibodies on the expression of Plasmodium 
immunogenic molecules. 
There are evidences that antibodies can interfere with 
parasite multiplication. An increase on sporozoite number 
recovered from the salivary glands when mosquitoes were 
fed on anti-Plasmodium antibodies was observed [3, 4] and 
IgG isolated from Kenyan immune adults enhanced 
parasite growth in culture while the serum from which 
they were isolated had an inhibitory effect [7]. The number 
of mature liver schizonts increased in the presence of mAbs 
anti-CSP of P. yoelii and the authors suggested that 
enhancement of infection could be a consequence of an 
interaction between the parasite and the host cell 
membrane [6]. Surface changes were also proposed by 
Peiris et al. [5] to explain enhanced transmission of P. vivax 
to the mosquito vector. In our model interactions at surface 
level are unlikely as CSP is not observed at the surface of 
blood stage parasites [12].  
CSP is a major protein at the sporozoite stage of 
Plasmodium and is normally referred as stage specific. 
However, the presence of Plasmodium csp transcripts have 
been described in erythrocytic forms [13, 14] and Cochrane 
et al. [12] isolated a protein from Plasmodium 
berghei erythrocytic stages that reacted with anti-CSP-mAb 
and had similar molecular mass and isoelectric points as 
the CSP isolated from the sporozoite stage. Although from 
literature we know that csp is not an essential gene during Int. J. Med. Sci. 2006, 3 
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P. berghei blood stage development, as disruption of csp 
gene had no effect on blood stage infection [15], our data 
suggests that CSP might play a role during the erythrocytic 
development of the parasite.  
Several functions have been described for CSP, 
sporozoite gliding motility [16] recognition and binding to 
the salivary glands [17] and more recently Thathy et al. [18] 
have demonstrated that CSP is essential for sporozoite 
morphogenesis in the oocyst. The effect observed at the 
present work indicates that availability of CSP during 
erythrocytic stages can interfere with parasite 
multiplication and invasion, suggesting that CSP is likely 
to be involved indirectly on erythrocyte invasion. The 
immune localisation of the CS-like protein described by 
Cochrane et al. [12] only found at the micronemes of 
merozoites of mature invasive blood stages is also 
indicative that CSP might play a role in the early stages of 
parasite interaction with the host red blood cell. 
Antibody dependent enhancement of viral 
replications has been described in several viruses 
(reviewed by Sullivan [19]). This phenomenon has been 
associated, with the ability of viruses to interfere with the 
activity of antiviral pathways, cytomegalovirus inhibited 
class II major histocompatibility complex expression in 
endothelial cells and fibroblasts [20] and Ross River virus 
interfered with transcription of key antiviral genes through 
targeting the transcription factors IRF-1 and NF-κB [21]. As 
virus relies on host cell machinery for multiplication, anti-
viral antibodies exert their effect on host cell. In malaria, 
the presence of CSP in the cytoplasm of HepG2 cells and 
macrophages has been described to inhibit protein 
synthesis in the target cells, through interaction with 
ribosomes [22]. Based on their observations the authors 
suggested that malaria sporozoites are able to control the 
protein synthesis machinery in cells of the vertebrate host, 
which could explain the differences in the levels of 
expression observed in our study. 
The effect of antibodies directed to an antigen 
predominantly expressed in a different life cycle stage, 
could contribute to parasite escape from destruction by 
influencing the efficacy of mechanisms such as host cell 
invasion. Parasite manipulation of their expression 
machinery by host immune system molecules might be a 
parasite mechanism that evolved to avoid potential lethal 
effects of neutralising Ab. 
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